VOYA Investment Management’s Accelerate Diagnostics AXDX Stock Holding History
Bought
Maintained
Sold
Other funds holding AXDX
GAM
OIM
BC
CC
CIA
BAM
VOYA Investment Management's AXDX Position: Q2 2022 in Review
VOYA Investment Management sold out of Accelerate Diagnostics (AXDX) in Q2 2022, closing a stake of 1,370 shares — an estimated $20K sold.
VOYA Investment Management first reported a position in AXDX in Q2 2014 and held it in 29 quarters. The position peaked at $333K in Q2 2017. 74 funds tracked by Wall St. Rank hold AXDX as of Q2 2022.
- VOYA Investment Management reported no remaining Accelerate Diagnostics position as of Q2 2022 after selling out during the quarter.
- VOYA Investment Management sold 1,370 Accelerate Diagnostics shares in Q2 2022, an estimated $20K.
- VOYA Investment Management first reported a position in Accelerate Diagnostics in Q2 2014 and held it in 29 quarters.
- VOYA Investment Management's Accelerate Diagnostics position peaked at $333K in Q2 2017.
- 74 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2022.
Based on VOYA Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.